MedDataToolRezvoglar is a long-acting insulin used to help manage blood sugar levels in adults and children with diabetes. It works by helping your body use sugar for energy and reducing the amount of sugar produced by the liver. You take it as an injection under the skin, once a day at the same time each day, starting with a dose of 0.2 units per kilogram of body weight or up to 10 units, and the maximum dose can be adjusted based on your needs. It's important to know that you should not use this medication if you are having low blood sugar episodes. Additionally, if you have type 1 diabetes, you will need to use it alongside short-acting insulin.
✦
Uses
- Type 1 diabetes.
- Type 2 diabetes.
◷
Dosage
Administer once daily at the same time each day.
Adjust dosage based on blood glucose levels and individual needs.
Do not mix with other insulins or solutions.
Inject into the abdomen, thigh, or deltoid.
Rotate injection sites to avoid skin problems.
Always follow your doctor's specific instructions for your dose.
⚠
Side effects
Common
hypoglycemiainjection site reactionsweight gainrashitchingswelling
Serious
allergic reactionssevere allergic reactionshypokalemialipodystrophy
🛑
Warnings
⚠ Important warnings
- Not for treating diabetic ketoacidosis.
- Monitor blood glucose closely when changing insulin types.
- Do not inject into areas with lipodystrophy.
- Increased risk of hypoglycemia with certain medications.
⇄
Drug interactions
- Antidiabetic agentsmay increase hypoglycemia riskCaution
- Corticosteroidsmay decrease blood glucose lowering effectCaution
- Beta-blockersmay mask hypoglycemia symptomsCaution
- Alcoholmay cause blood glucose fluctuations.Caution
Ask about this drug
Answers pulled from the FDA label only.
Medical Disclaimer: This content is provided for informational and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before taking any medication.
Data Source: Publicly available drug labeling information from the U.S. Food and Drug Administration (FDA).
Data Source: Publicly available drug labeling information from the U.S. Food and Drug Administration (FDA).